Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diabeloop SAS

http://www.diabeloop.fr

Latest From Diabeloop SAS

Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021

The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021. 

Market Intelligence Diabetic Care

Of Mice and Men: Predictive Toxicology

Current in vivo and in vitro models can't keep up with the demand for the safety assessment of large numbers of compounds emerging from high-throughput strategies. Pharmaceutical companies and start-ups are therefore building new systems that they hope will be capable of predicting the toxicity liabilities of new compounds. Cheminformatics can help week out toxic compounds at the lead selection and optimization stage; toxicogenomics may provide a toxicity diagnostic capability at all stages of drug development. For both toxicology approaches, there is not yet enough high quality data to build predictive models. Toxicology-focused cheminformatics programs attempt to consolidate data from hitherto untapped sources; toxicogenomics companies are engaged in the fussy and expensive process of manufacturing data from scratch and validating them with biological experiments.

Clinical Trials Regulation

Columbus Molecular Software Inc.

Three scientists who had worked for Chemical Abstracts Service decided to create Columbus Molecular Software when they saw how chemists were being overloaded with data from automated chemical synthesis and screening operations. As with other data mining firms, CMS's idea is to help scientists turn data into useful knowledge.

BioPharmaceutical Research and Development Strategies
See All

Company Information

  • Industry
  • Digital Health
  • Medical Devices
    • Monitoring Equipment & Devices
UsernamePublicRestriction

Register